Global Molecular Diagnostics Strategic Business Report 2015-2022 - HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market

Dublin, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications:

• Infectious Disease Testing
• Blood Screening
• Cancer Screening
• Other Applications

The report profiles 145 companies including many key and niche players such as

• Abbott Laboratories (US)
• Abbott Molecular, Inc. (US)
• Becton, Dickinson and Company (US)
• bioMérieux SA (France)
• Cepheid (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• RMD's Product Portfolio by Segment
• RMD's Major Test Offerings by Application
• GE Healthcare (US)
• Grifols International, S.A. (Spain)
• Hologic, Inc. (US)
• QIAGEN N.V. (The Netherlands)
• Quest Diagnostics, Inc. (US)
• Siemens Healthcare GmBH (Germany)
• Tecan Group Ltd. (Switzerland)
• The ELITechGroup SAS (France)
• Thermo Fisher Scientific (US)

Key Topics Covered:

1. OUTLOOK
Global In-Vitro Diagnostics (IVD) Market on a Steady Growth Path
Molecular Diagnostics
A Rapidly Expanding Segment of the IVD Market
PCR Technology Leads the MDx Market
Current and Future Analysis
US and Europe
Leaders in Molecular Diagnostics Adoption
Developing Countries Excel in Growth Prospects
Major Growth Drivers
Key Market Trends in a Nutshell
Major Technology Trends
Advancements in Molecular Diagnostics
A Boon for the Industry
Major Issues and Challenges
Market Outlook

2. GROWTH DRIVERS AND MARKET TRENDS
Aging Population Drives Molecular Diagnostics Market
Global Aging Population Statistics
Opportunity Indicators
Technological Innovations Set to Drive the Market
The Role of Molecular Diagnostics in Personalized Medicine
Companion Diagnostics Make Way for Personalized Medicine
List of Select FDA-Cleared Companion Diagnostic Devices
Biomarkers as Companion Diagnostics
Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth
Proteomics Technologies: Growing in Significance
New Developments in Proteomics Technologies
New Applications Hold Promising Potential
Molecular Diagnostics for Lymphoid Malignancies
Next-Generation Sequencing Technologies Keep Up the Momentum
Select Commercial NGS Technologies
Rising Emphasis on Lab Automation to Augur Well for Market Growth
List of Fully Automated and Rapid Molecular Diagnostics
Molecular Diagnostics and Intellectual Property
Molecular Diagnostics
Moving from Centralization to Decentralization
Limited Reimbursements by Third Party Payers
A Stumbling Block

3. APPLICATION AREAS OF MOLECULAR DIAGNOSTICS
Infectious Diseases
Bright Prospects Ahead for Molecular Diagnostics for Testing Infectious Diseases
Leading Players
Key Trends
Increasing Incidence of Infectious Diseases Fuels Adoption
Rising Incidence of Hospital Acquired Infections Propels Market Growth
Rising HIV Prevalence Provides Ample Growth Opportunities
Infectious Disease Testing
A Major Driver of Molecular Diagnostics Market
Select FDA-Cleared Molecular Diagnostic Tests for Infectious Diseases
Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
List of Select HPV Molecular Diagnostic Tests by Company and Technique
Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
Major Risk Factors to HPV/Cervical Cancer
HPV Testing for Primary Screening Indication Bodes Well for the Market's Growth
Archaic TB Diagnostic Methods Opens Up Opportunities for Molecular Diagnostics
List of Select Commercially-Available TB Diagnostics
An Overview of Select TB Diagnostics under Development
Molecular POC Testing for Infectious Diseases: Yet to Realize Its Full Potential
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Blood Screening
Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
Cancer Screening & Diagnosis
Overview
Molecular Tests Lead the Way for Cancer IVD Market Growth
Molecular Markers to Enhance Thyroid Cancer Diagnosis
Oncology-Based Molecular Diagnostics: The Propitious Segment
List of US-FDA Approved Biomarkers for Cancer
Growing Popularity of Chemo-Sensitivity Testing of CTCs
Cervical Cancer Screening: Focus on Detection of CIN2 and CIN3 Cancers
Other Testing Applications
Genetic Disease Testing Applications
Overview
Pharmacogenomics
Prognosis Based on Genomics
Pharmacogenomics Development Augurs Growth of Genetic Testing Market
Prospects for Genetic Diagnostics and Testing Grow Brighter
List of Select FDA-Cleared Genetic Tests by Disease
Genetic Testing
An Indispensible Tool for Cystic Fibrosis
Genetic Testing Plays Pivotal Role in Diagnosing Inherited Conditions
Non-Invasive Prenatal Diagnostics
The Way Ahead
Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
Histocompatibility Testing

4. COMPETITIVE DYNAMICS IN THE MOLECULAR DIAGNOSTICS MARKET
An Overview of Competitive Landscape in Molecular Diagnostics
Other Noteworthy Companies and their Competitive Position by Segment
Key Players and Their Technologies
The Top Tier
Mid-Sized and Small Companies
Cepheid: Unquestioned Leader in the Rapid and Automated MDx Market
Qiagen: The Leading Player in the Global HPV MDx Market
Comparative Analysis of Select HPV MDx Tests
Competitive Dynamics in the C. difficile Testing Market
List of Select Molecular C. difficile Test Products
Competition in the Blood Screening MDx Market
Pharmaceutical Firms Carving Their Niche in Molecular Diagnostic Market
Competitive Landscape in the Global RT-PCR Market
Thermo Fischer, Bio-Rad, Roche, Agilent, Qiagen and Others (includes corresponding Graph/Chart)
Select Real-Time PCR Products by Company
Competition Heats Up in dPCR Market
Life Sciences Companies Eye on Lucrative Prostate Cancer MDx Market
Consolidation Activity Continues to Strengthen Driven by New Entrants
Major M&A Transactions in Molecular Diagnostics: 2011-2016
Product Marketing
Key to Commercial Success

5. PRODUCT & TECHNOLOGY OVERVIEW
Molecular Diagnostics
Definition & Scope
Molecular Diagnostics
Impact on Healthcare
Utility of Molecular Diagnostic Tests
Background of Molecular Diagnostics
Major Milestones in the Evolution of Molecular Diagnostics
Types of Molecular Diagnostics
Conventional Diagnostics Vs. Molecular Diagnostics
Unabated Developments in Molecular Diagnostics Technology
Signal Amplification Technologies
PCR
New Developments
Quantitative Real-Time PCR for Molecular Diagnostics
Signal Detection and Quantification
Quantitative Real-Time RT-PCR Analysis
Applications of Quantitative Real-Time PCR Analysis
Digital PCR
Non-PCR Methods
Other Signal Amplification Technologies
DNA Probe Based Products
Direct Detection of Specific Nucleic Acid Sequences
Nucleic Acid Amplification and Detection
DNA Sequencing and Gene Detection
Arrays of Immobilized Probes (DNA Chips) in Gene Detection
RNA Diagnostics
Complementary Molecular Diagnostic Technologies
Fluorescent In-Situ Hybridization (FISH)
DNA Biochips/Microarrays
Biosensors
Proteomic Technologies for Molecular Diagnostics
Nanotechnology for Molecular Diagnostics
Technologies on the Anvil
Haplotype Analysis
A Distant Possibility
Chronic Multi-Gene Defects Now Diagnosable
Whole Genome Sequencing
A Boon or a Bane to Genetic Testing?

6. PRODUCT APPROVALS/INTRODUCTIONS
Qiagen Introduces New Diagnostic Test for Cervical Cancer
GE Showcases Discovery MI and Discovery NM/CT 670 CZT
Quest Launches New Tests for Determining Hereditary Cancer
Predictive Launches Test for Spine Deformities
LabCorp® Introduces Epi proColon®
Agena Rolls Out MassARRAY® Dx
Rosetta Introduces Three New Diagnostic Offerings
bioMérieux Rolls Out GENE-UP®
Roche Introduces New cobas Range
Quest Launches Dako's PD-L1 Complementary Diagnostic Test
Quest Introduces Dako's PD-L1 Tests for KEYTRUDA®
Clarient Rolls Out PD-L1 Test for KEYTRUDA®
Pathway Unveils CancerIntercept
Cepheid Unveils Xpert® Carba-R update
Cepheid Launches GeneXpert® Omni
AlphaImpactRx Introduces BrandImpactDx
BioNTech AG Introduces MammaTyper®
EKF Showcases Molecular Diagnostics Products Series
Microbix Unveils New Molecular Diagnostics Range
Roche Introduces cobas® Liat System
Quest Unveils BRCAvantage Plus
Cepheid Rolls Out Xpert® TV
OpGen Introduces Acuitas MDRO Gene Test
DaVita Introduces Molecular Diagnostic Testing
Grifols Obtains CE-Marking for ID CORE XT Molecular Diagnostic Kit
QIAGEN Rolls Out careHPV Test in India
QIAGEN Gets PMA Approval from the US FDA for artus® CMV RGQ MDx Kit
Alere Obtains FDA Approval for Alere i Influenza A and B Test
Qiagen Obtains Approval from the US Health Regulators for Gene-Testing Kit
Immucor Obtains the US FDA Approval for PreciseType HEA Test
Biocartis Introduces Idylla
Roche Introduces cobas 6800/8800 Systems
Roche Unveils CINtec PLUS*
Roche Rolls Out cobas® HIV-1 and cobas HCV assays

7. RECENT INDUSTRY ACTIVITY
Bio-Techne to Acquire Advanced Cell Diagnostics
Myriad Acquires Sividon Diagnostics
Siemens Acquires Neo New Oncology
Luminex to Acquire Nanosphere
DiaSorin Completes Acquisition of Focus Diagnostics
Avant Acquires Amarantus Diagnostics
HTG to Collaborate With Bristol-Myers Squibb
Miroculus to Acquire Kapplex
Cepheid's Xpert® MRSA NxG Gets European Approval
SpeeDx Collaborates with Goffin Molecular
FDA Approves BD's Totalys
CE Mark Approves BioFire Diagnostics' FilmArray®
Thermo Fisher Acquires Affymetrix
Qiagen Collaborates with Mirati
BioGenex to Commence Operations from India Center
Illumina Collaborates with investors to Launch GRAIL
Thermo Fisher Collaborates with Karolinska Institute
CE Mark Approves Aptima® HCV Quant Dx Assay by Hologic
FDA Approves BioFire Diagnostics' FilmArray®
ERBA Acquires Lumora
Seegene Collaborates with BD Life Sciences
MDxHealth to Acquire NovioGendix
Quest's Simplexa HSV 1 & 2 Test Gets FDA 510(k) Approval
Burning Rock Partners with Illumina
GE's Low Dose CT Screening Approved by FDA
Roche to Acquire GeneWEAVE BioSciences
Cancer Genetics Acquires Response Genetics, Inc
OpGen Acquires AdvanDx
Hitachi Collaborates with QIAGEN
OPKO Takes Over Bio-Reference Laboratories
Sysmex Signs Agreement with IndivuTest
CE Mark Approves Xpert® HIV-1 Qual by Cepheid and FIND
Xpert® HCV Viral Load by Cepheid gets CE Mark Approval
Rosetta Acquires CynoGen
Microbix Signs Agreement with Microbiologics
Cepheid Receives Emergency Use Authorization by FDA for Ebola Test
Novigenix Acquires Colox®
Roche Takes Over Signature Diagnostics
CE Mark Approves QIAGEN's Circulating Tumor DNA Test
Amarantus Completes Acquisition of DioGenix
Aegis Acquires Diagnovus
Empire Announces Acquisition of ID Labs
OncoGxSelect Receives NJDH Approval
Roche Takes Over Ariosa
FDA Approves Xpert® Norovirus by Cepheid
Cepheid's Xpert® Flu/RSV XC Gets FDA Approval
Roche's cobas® Strep A Test Receives 510(k) Clearance
PDI Takes Over RedPath
Veracyte Acquires Allegro Diagnostics
GTCR Takes Over XIFIN
QIAGEN to Collaborate with AstraZeneca
BD Collaborates with MD Anderson Cancer Center
Roche Acquires IQuum
Myriad to Acquire Crescendo Bioscience
Co-Diagnostics Unveils Co-Dx
bioMérieux Acquires BioFire Diagnostics
Thermo Fisher Scientific Acquires Life Technologies
Myriad Genetics Takes Over Crescendo Bioscience
AUT University Collaborates with Roche Diagnostics
Corgenix Medical Obtains NIH Grant to Advance Development of Ebola Rapid Diagnostic Test Kit
Cepheid Collaborates with AstraZeneca, Cubist Pharmaceuticals and GSK
B Braun US and CeGaT Join Forces to Establish B Braun CeGaT
Provista Diagnostics Expands Exclusive License Agreement for Certain Biomarker and Autoantibody Technologies
Veracyte and Fleury Partner to Offer the Afirma® Gene Expression Classifier
Integrated Diagnostics Attracts Financing for Xpresys Lung Molecular Diagnostic Blood Test
MDxHealth Enters into Agreement with Galaxy Health
QIAGEN Acquires Exclusive Worldwide License to CALR Biomarker
Zyomyx Obtains $7.5 Million from UNITAID to Launch MyT4 POC CD4 Test
Human Longevity Inc. Commences its Operations
Roche Takes Over IQuum
Myriad Genetics and Sividon Diagnostics Ink Exclusive Co- Marketing Agreement

8. FOCUS ON SELECT PLAYERS

9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 145 (including Divisions/Subsidiaries 162)

• The United States (99)
• Canada (2)
• Europe (50)
• - France (5)
• - Germany (11)
• - The United Kingdom (12)
• - Italy (2)
• - Spain (1)
• - Rest of Europe (19)
• Asia-Pacific (Excluding Japan) (10)
• Middle East (1)
  

For more information about this report visit http://www.researchandmarkets.com/research/p4hz9g/molecular

Related Topics: In Vitro Diagnostics, Molecular Diagnostics

                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                    
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    
                             U.S. Fax: 646-607-1907
                             Fax (outside U.S.): +353-1-481-1716